2019
DOI: 10.4317/medoral.23095
|View full text |Cite
|
Sign up to set email alerts
|

Effect of preemptive dexamethasone and etoricoxib on postoperative period following impacted third molar surgery - a randomized clinical trial

Abstract: Background The aim of this study was to compare the anti-inflammatory effects of dexamethasone and etoricoxib after third molar extraction. Material and Methods A prospective, randomized, controlled, split-mouth study was conducted. 19 volunteers were allocated randomly to receive 90mg etoricoxib 1 hour prior to the procedure or 4mg intramuscular dexamethasone immediately after anesthesia. Baseline measurements were obtained preoperatively, and subsequent assessments were made on immediate postoperative, at … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 22 publications
0
10
0
2
Order By: Relevance
“…Oral Etirocoxib [10,22], celecoxib [11], acetaminophen [11], dexamethasone [17,21,24,25,35,36,39], diclofenac [17,36], codeine [17], ketorolac [19,21,43], methylprednisolone [25,35], paracetamol [26,48], dexketoprofen [26], ibuprofen [39,47,48], tramadol [40], nimesulide [40], ketoprofen [44], diflunisal [46], lornaxicam [46], rofecoxib [47].…”
Section: Nomentioning
confidence: 99%
See 1 more Smart Citation
“…Oral Etirocoxib [10,22], celecoxib [11], acetaminophen [11], dexamethasone [17,21,24,25,35,36,39], diclofenac [17,36], codeine [17], ketorolac [19,21,43], methylprednisolone [25,35], paracetamol [26,48], dexketoprofen [26], ibuprofen [39,47,48], tramadol [40], nimesulide [40], ketoprofen [44], diflunisal [46], lornaxicam [46], rofecoxib [47].…”
Section: Nomentioning
confidence: 99%
“…Intramuscular Dexamethasone [10], diclofenac [18,27], ketorolac [18,30], tramadol [19,30,42,45], ketoprofen [27], meloxicam [42], 3.…”
mentioning
confidence: 99%
“…Participants were eligible if all inclusion criteria were met: (1) age 18 years or older; (2) absence of systemic diseases with patients classified as ASA I according to American Society of Anesthesiologists (ASA) classification criteria; (3) abstinence from the use of analgesic, anti-inflammatory, and/or antipyretic drugs in the previous seven days; (4) absence of patient allergy to the molecule and/or excipients of the drugs used; (5) absence of infectious foci at the surgical site and/or absence of symptoms; and (6) mandibular third molars with complete clinical-radiographic indication of disodontiasis of the included or semi-included mandibular third molar intended for extraction [ 10 , 18 , 19 ]. Ineligibility for study participation was verified if participants met at least one of the following exclusion criteria: (1) pregnant or breastfeeding; (2) history of gastrointestinal ulcer or peptic ulcer events; (3) allergy to aspirin or other non-steroidal anti-inflammatory drugs; (4) systemic diseases affecting the kidneys, liver, blood, or central nervous system; (5) abuse of psychostimulant substances, analgesics, steroids, and/or non-steroidal anti-inflammatory drugs; and (6) use of contraceptives [ 10 , 18 , 19 ]. Patients were excluded if they did not complete the study or strictly adhere to the study protocol.…”
Section: Methodsmentioning
confidence: 99%
“…Often related to the aforementioned complications is the development of postoperative edema and swelling, 20,21,23,30,41 although it is not necessarily associated with hematoma or petechiae development. Evidence originating solely from impacted third molar extraction studies indicates that it is possible to limit postoperative swelling with pre‐emptive use of prescription anti‐inflammatory medication 42,43 ; however, there are no pertinent studies in the RAP literature.…”
Section: Complications By Tissue Typementioning
confidence: 99%